CN Patent

CN109896997A — N－酰基苯胺类c－Met激酶抑制剂的制备方法及其用途

Assigned to China Pharmaceutical University · Expires 2019-06-18 · 7y expired

What this patent protects

本发明涉及药物化学领域，具体涉及N‑酰基苯胺类衍生物、它们的制备方法、含有这些化合物的药用组合物以及它们的医疗用途，特别是作为c‑Met激酶抑制剂的用途。

USPTO Abstract

本发明涉及药物化学领域，具体涉及N‑酰基苯胺类衍生物、它们的制备方法、含有这些化合物的药用组合物以及它们的医疗用途，特别是作为c‑Met激酶抑制剂的用途。

Drugs covered by this patent

cabozantinib-s-malate (CABOZANTINIB S-MALATE)

Patent Metadata

Patent number: CN109896997A
Jurisdiction: CN
Classification: —
Expires: 2019-06-18
Drug substance claim: No
Drug product claim: No
Assignee: China Pharmaceutical University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.